Abstract
Study of stem cells by methods of molecular and cellular biology brings us closer to understanding the basis of life. At the same time, the problem of stem cells has great social resonance caused, first of all, by their potential to treat pancreatic diabetes, Parkinson’s and Alzheimer’s diseases, and cardiovascular diseases. Prospects for stem cells in medical practice and the ethical problems that arise are discussed.
Similar content being viewed by others
References
C. Mason and P. Dannill, “A Brief Definition of Regenerative Medicine,” Regenerative Med. 3, 1 (2008).
C. V. Weaver and D. J. Garry, “Regenerative Biology: A Historical Perspective and Modern Applications,” Regenerative Med. 3, 63 (2008).
T. Salaway and D. Ilic, “Logistics of Stem Cell Isolation, Preparation, and Delivery for Heart Repair: Concerns of Clinicians, Manufacturers, Investors, and Public Health,” Regenerative Med. 3, 83 (2008).
L. Hecker and R. K. Birla, “Engineering the Heart Piece by Piece: State of the Art in Cardiac Tissue Engineering,” Regenerative Med. 2, 125 (2007).
A. Reinisch et al., “Humanized System to Propagate Cord Blood-Derived Multipotent Mesenchymal Stromal Cells for Clinical Application,” Regenerative Med. 2, 371 (2007).
I. M. Verma and M. D. Weitzman, “Gene Therapy: Twenty-First Century Medicine,” Annu. Rev. Biochem. 74, 711 (2005).
S. Dimmeler and A. M. Zeiher, “Vascular Repair by Circulating Endothelial Progenitor Cells: The Missing Link in Atheroscrerosis,” J. Mol. Med. 82, 671 (2005).
R. Ogawa, K. Oki, and H. Hyakusoku, “Vascular Tissue Engineering and Vascularized 3-D Tissue Regeneration,” Regenerative Med. 2, 831 (2007).
E. Mezey, “Bone Marrow-Derived Stem Cells in Neurological Diseases: Stones or Masons?” Regenerative Med. 2, 51 (2007).
A. E. Willing, D. J. Eve, and P. R. Sanberg, “Umbilical Cord Blood Transfusions for Prevention of Progressive Brain Injury and Induction of Neural Recovery: An Immunological Perspective,” Regenerative Med. 2, 457 (2007).
P. Bianco and R. P. Geron, “Skeletal Stem Cells,” in Handbook of Adult and Fetal Stem Cells, Ed. by R. P. Lanza, H. M. Blau, D. A. Melton, et al. (Academic Press, New York, 2004), Vol. 2.
J. A. Korecka, J. Verhaagen, and E. M. Hol, “Cell-Replacement and Gene-Therapy Strategies for Parkinson’s and Alzheimer’s Disease,” Regenerative Med. 2, 425 (2007).
J. M. Rukstralis and J. F. Yodtner, “Islets Break off from the Mainland,” Nature Med. 12, 273 (2006).
K. A. Krishna, G. W. Rao, and K. R. S. S. Rao, “Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus,” Regenerative Med. 2, 171 (2007).
B. Salter, “Patenting, Morality, and Human Embryonic Stem Cell Science: Bioethics and Cultural Politics in Europe,” Regenerative Med. 2, 301 (2007).
“More Than Skin Deep: Stem Cells from Human Skin Cells,” Regenerative Med. 3, 7 (2008).
J. T. Daniels, “Stem Cells: Moving the Biology Towards the Clinic,” Regenerative Med. 2, 313 (2007).
M. J. Sullivan, “Banking on Cord Blood Stem Cells,” Nature Rev./Cancer 8, 554 (2008).
Additional information
Original Russian Text © M.A. Pal’tsev, V.N. Smirnov, A.A. Ivanov, 2009, published in Vestnik Rossiiskoi Akademii Nauk, 2009, Vol. 79, No. 11, pp. 1012–1019.
RAS Academician Mikhail Aleksandrovich Pal’tsev is rector of the Sechenov Medical Academy, Moscow, and a full member of the Russian Academy of Medical Sciences. RAS Corresponding Member Vladimir Nikolaevich Smirnov is director of the Institute of Experimental Cardiology of the Russian Ministry of Health and Social Development and a full member of the Russian Academy of Medical Sciences. Prof. Aleksei Alekseevich Ivanov is a deputy director of the Research Institute of Molecular Medicine at the Sechenov Medical Academy, Moscow.
Rights and permissions
About this article
Cite this article
Pal’tsev, M.A., Smirnov, V.N. & Ivanov, A.A. Outlook for stem cells in medicine. Her. Russ. Acad. Sci. 79, 587–592 (2009). https://doi.org/10.1134/S1019331609060112
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1019331609060112